BRCA1/2携带者对子宫内膜癌风险的认知调查
该研究对332名BRCA1/2致病性变异携带者进行电子调查,评估其对子宫内膜癌风险的知识、信息来源偏好及风险容忍度。结果显示携带者对子宫内膜癌风险认知有限,且接受的子宫切除术咨询不一致。
要点
- 携带者对子宫内膜癌风险因素认知不足,大量回答为「不知道」。
- 若子宫内膜癌风险≥15%,42.2%的子宫完整女性愿意接受子宫切除术。
- 提供者关于子宫切除术的建议不一致。
核心结论
- 许多BRCA1/2携带者对子宫内膜癌风险知识有限,且未获得一致的子宫切除术咨询。
研究设计与样本
- 对332名匿名女性BRCA1/2致病性变异携带者进行电子调查,采用描述性统计。
主要发现
- 参与者中非西班牙裔白人占89.3%,美国居民占91.7%,平均年龄45岁;BRCA1携带者占50.6%,BRCA2携带者占45.7%。
- 56.7%的参与者曾接受降低风险手术,其中44.3%进行了子宫切除术;子宫切除术的主要原因包括医生建议和子宫内膜癌风险。
- 子宫完整的女性中,42.2%表示若子宫内膜癌风险≥15%会接受子宫切除术。
- 对特定子宫内膜癌风险因素,30.9%-75.5%的回答为「不知道」风险是增加还是降低;针对BRCA1为55.2%,针对BRCA2为72.6%。
- 参与者偏好信息来源依次为妇科肿瘤医生、肿瘤内科医生、遗传咨询师和妇科医生。
临床怎么用
- 临床医生应向BRCA1/2携带者提供关于子宫内膜癌风险的明确教育和一致的子宫切除术咨询。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To survey knowledge, preferred information sources, and risk tolerance for EC among BRCA1 and BRCA2 pathogenic variant (PV) carriers. METHODS: Electronic survey of 332 anonymous women. Descriptive statistics presented. RESULTS: Participants included non-Hispanic White (89.3%) United States residents (91.7%), with mean age of 45 years; 50.6% were BRCA 1 and 45.7% were BRCA 2 carriers; 56.7% had undergone risk-reducing surgery, including hysterectomy in 44.3%. Most cited reasons for hysterectomy were physician recommendation and EC risk. Among women with intact uteri, 42.2% or participants indicated that they would undergo hysterectomy if EC risk was ≥15%. When queried about specific EC risk factors, responses of "don't know" (if risk is increased or decreased) were given for 30.9%-75.5%, and specifically for BRCA1: 55.2% and for BRCA2: 72.6%. Participants expressed preferences for sources of information about EC risk (decreasing order) as gynecologic oncologists; medical oncologists; genetic counselors and gynecologists. Respondents indicated that providers recommended hysterectomy for 36.0%, against hysterectomy for 15.7% or gave conflicting information for 16.6%. CONCLUSIONS: Many carriers have limited knowledge of EC risk and do not receive consistent counseling about hysterectomy.
引用
- Sherman ME, Pacheco-Spann L, Friedman S, et al. BRCA1 and BRCA2 carriers: Perceptions of endometrial cancer risk. Gynecol Oncol. 2026. PMID: 41619719. doi:10.1016/j.ygyno.2026.01.235
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。